<DOC>
	<DOCNO>NCT01006941</DOCNO>
	<brief_summary>The hypothesis study treatment Trichuris suis ovum safe effective oral treatment patient relapse multiple sclerosis .</brief_summary>
	<brief_title>Trichuris Suis Ova Therapy Relapsing Multiple Sclerosis - Safety Study</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<criteria>age 19 55 year relapse course multiple sclerosis ( relapsingremitting secondary progressive MS relapse duration disease least 1 year disease modify therapy unchanged immunomodulatory therapy last 3 month least 2 documented relapse last 24 month last relapse within last 12 month pregnancy period breastfeed miss adequate contraceptive protection female premenopausal patient relapse last month prior enrolment treatment steroid last 30 day previous treatment mitoxantroneduring last year previous treatment cyclophosphamide intensive immunosuppression , total irradiation treatment glatiramer acetate , azathioprine , IVIG immunosuppressive immunomodulatory drug apart interferonbeta 6 month prior enrolment cardiac insufficiency ( NYHA III/IV ) , cardiomyopathy , significant cardiac dysrhythmia require treatment , instable advanced ischemic heart disease ( CCS III IV ) , malignant hypertension diabetes mellitus autoimmune disease history renal insufficiency stay tropical area last 3 month eosinophilia blood ( &gt; 0,45 billion/l ) concurrent systemic infection</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>Multiple sclerosis</keyword>
	<keyword>safety</keyword>
	<keyword>MRI</keyword>
	<keyword>immunological</keyword>
	<keyword>Helminths</keyword>
	<keyword>Trichuris suis</keyword>
</DOC>